DC371739 is a potent and orally activity PCSK9 inhibitor. DC371739 decreases the mRNA expression of PCSK9 and ANGPTL3. DC371739 decreases the protein expression of PCSK9 and increases the protein expression of LDLR. DC371739 has the potential for the research of hyperlipidemia[1][2].
Molecular Weight:
470.56
Purity:
95.56
CAS Number:
[2135765-21-6]
Formula:
C29H30N2O4
Target:
ANGPTL,PCSK9
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
